top of page

Amyotrophic Lateral Sclerosis (ALS)

Behaviour

    Apathy
    Aggression
    Disinhibition
    Loss of empathy
    Fixation
    Anxiety and depression
    Lack of Sleep

Biomarkers

    Neurofilament light chain (NfL)
    TDP-43
    Progranulin
    Phosphorylated neurofilament heavy (pNfH)

Pathology

    Neurons in the brain, brainstem, and spinal cord
    Loss of axons
    Oxidative stress
    Gliosis

Huntington's Disease (HD)

Behaviour

    Mood swings: Feeling irritable, depressed, or angry
    Apathy: Lack of interest in things
    Impulsiveness: Acting without thinking, or outbursts
    Social Isolation
    Lack of awareness
    Communication difficulties

Biomarkers

    Neurofilament light chain (NEFL)
    Tau
    YKL-40
    Caudatend putamen volume loss

Pathology

    Striatum
    Thalamus
    Cortex
    Peripheral tissues
    Motor defects

Alzheimer’s Disease and Dementia

Behaviour

    Agitation
    Aggression
    Depression & Anxiety
    Memory loss
    Hallucinations

Biomarkers

    Amyloid beta (Aβ)
    Tau
    Neurofilament light chain (NfL)
    Beta-amyloid 42

Pathology

    Amyloid plaques
    Neurofibrillary tangles
    Loss of neurons
    Vascular dementia

Diabetic Neuropathy

Behaviour

    Depression
    Fear of falling
    Disability
    Weight loss

Biomarkers

    Monocyte chemoattractant protein-1 (MCP-1)
    Soluble ICAM-1nd IL-1
    Nuclear factor (erythroid-derived 2) (NFE2L2)
    Calprotectin
    microRNAs

Pathology

    Nerve fiber loss
    Microangiopathic changes
    Vascular changes
    Reactive oxygen species

Alpers' Syndrome

Behaviour

    Seizures
    Developmental delays
    Intellectual decline
    Sleepiness, irritability, and memory loss
    Irritability
    Migraine headaches

Biomarkers

    Genetic testing
    Cerebrospinal fluidnalysis
    Liver biopsy
    Mitochondrial DNA depletion

Pathology

    Gray matter degeneration
    Cortical atrophy
    Signal abnormalities
    Reactive astrogliosis
    Optic atrophy

Canavan Disease

Behaviour

    Poor head control
    irritability
    quietness
    lack of interest or emotion
    Sleep disturbances

Biomarkers

    N-acetylasparticcid (NAA)
    Aspartoacylasectivity
    ASPA gene

Pathology

    Spongiform degeneration
    Vacuolization
    Dilated ventricles
    Dysmyelination
    Swollen astrocytes

Demyelinating Diseases

Behaviour

    Anxiety,
    Depression
    Vision changes
    Muscle weakness
    Balance problems

Biomarkers

    Aquaporin-4 (AQP-4)
    Glialcidic fibrillary protein (GFAp)
    S100β
    CHI3L1

Pathology

    Demyelination
    Sclerosis
    Lesions

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Behaviour

    Progressive weakness
    Gait difficulties
    Fatigue
    Muscle atrophy
    Neuropathic pain

Biomarkers

    Serum glycoproteins
    Neurofilament light chain (NFL)
    Immune cell subsets
    Clinical heterogeneity

Pathology

    Demyelination
    Onion bulb formation
    Nerve biopsy
    Axonal damage
    Immune-mediated

Encephalitis

Behaviour

    Memory loss
    Anxiety
    Irritability
    Weakness or loss of movement
    Loss of consciousness

Biomarkers

    Neurofilament light chain (NfL)
    Chitinase 3-like 1nd complement factors
    Autoantibodies: Suchs DPPX, IgLON5,nd neurexin-3α
    IgGntibodiesgainst the GluN1 subunit of the NMDAR

Pathology

    Viral infections
    Arboviruses
    Autoimmune responses: NMDAR

Hallervorden-Spatz Syndrome

Behaviour

    Vision loss
    Personality Changes
    Depression & Anxiety
    Obsessive Compulsive Disorder
    Psychosis

Biomarkers

    Ironccumulation
    PANK2 gene mutations
    Post-mortem findings
    Genetic testing

Pathology

    Brain degeneration
    Corticospinal signs
    Iron deposition
    Spheroid formation
    Glial reaction

Kearns-Sayre Syndrome (KSS)

Behaviour

    Decreased motivation
    Frustration and irritability
    Social withdrawal
    Anxiety and depression
    Difficulty with coordination and balance (ataxia)

Biomarkers

    Genetic testing
    Muscle biopsy
    Cerebrospinal fluid (CSF) tests
    Blood tests: Serum creatinine kinase level
    Urine tests: pH, protein, glucose

Pathology

    Mitochondrial dysfunction
    Oxidative phosphorylation impairment
    Cerebellar dysfunction
    Heteroplasmy

MELAS

Behaviour

    Confusion
    Hallucinations
    Depression & anxiety
    Partial loss of vision or hearing

Biomarkers

    Lactate
    ATP
    Creatine
    Lipidccumulation
    FGF21

Pathology

    Mitochondrial dysfunction
    Vascular abnormalities
    Nitric oxide deficiency
    Ocular pathology
    Genetics: mutations are A3243G and T3271C

Mitochondrial Diseases

Behaviour

    Anxiety and depression
    Speech disturbances
    Muscle weakness
    Vision and hearing loss

Biomarkers

    Lactatend pyruvate
    Aminocids
    Acylcarnitines
    Organiccids
    FGF21nd GDF15

Pathology

    Ragged red fibers
    Cytochrome-c-oxidase (COX) negative fibers
    Neuronal loss
    Gliosis
    Demyelination

Polymyositis and Dermatomyositis

Behaviour

    Weight loss
    Muscle pain
    Muscle weakness
    Fatigue
    Difficulty swallowing or breathing

Biomarkers

    Muscle biopsy
    Anti-transcription intermediary factor 1-γ (TIF1-γ)ntibodies
    Classic biomarkers
    Myxovirus resistance protein 2

Pathology

    Muscle fiber damage
    Capillary damage
    Endoplasmic reticulum stress

Prion Diseases
1. Creutzfeldt-Jakob Disease (CJD)
2. Gerstmann-Sträussler-Scheinker Syndrome (GSS)
3. Fatal Familial Insomnia (FFI)
4. Kuru

Behaviour

    Aggression
    Loss of interest
    Depression & Anxiety
    Obsessional or paranoid behavior
    Withdrawing

Biomarkers

    14-3-3 proteins
    Tau protein
    NfL
    Alpha-nd beta-synuclein, GFAP,ndβ40/42

Pathology

    Neuronal loss and gliosis also occur
    Amyloid plaques
    Spongiform change
    Neuronal loss
    Gliosis

Shy-Drager Syndrome

Behaviour

    Uncontrollable laughing or crying
    Movement and coordination issues
    Vision changes
    Muscle issues
    Breathing issues

Biomarkers

    Alpha-synuclein
    Iron
    Phosphoprotein-25α (p25α)
    MicroRNA transcriptomics

Pathology

    Ventral horn cell loss
    Striatonigral degeneration
    Olivopontocerebellar atrophy
    Pyramidal tract degeneration
    Autonomic nuclei loss

Subacute Sclerosing Panencephalitis (SSPE)

Behaviour

    Mood swings
    Irritability
    Social withdrawal
    Hallucinations
    Sleeplessness

Biomarkers

    Measlesntibody titers
    CSF γ-globulin
    Electroencephalography
    Brain biopsy

Pathology

    Astrocytosis
    Viral inclusions
    Neurofibrillary tangles
    Demyelination
    Neuronal loss

Tay-Sachs Disease

Behaviour

    Vision loss or blindness
    Irritability
    Listlessness
    Dementia (loss of brain function)
    Muscle weakness

Biomarkers

    Lyso-GM2 ganglioside
    Hexosaminidase enzyme levels
    Urinary oligosaccharides

Pathology

    Enzyme deficiency: mutation in the HEXA gene
    Inherited in an autosomal recessive manner.
    Ganglioside accumulation
    Microglia proliferation

Tremor Disorders

Behaviour

    Stress, anxiety, or fatigue
    Depression
    Social phobia
    Avoidant personality types
    Shaking or trembling

Biomarkers

    Accelerometers
    Electroencephalography (EEG)
    Electromyography (EMG)
    Fluid-based tests

Pathology

    Purkinje cell damage
    Cerebellar degeneration
    Climbing fiber changes
    Basket cell changes

Parkinson's Disease (PD)

Behaviour

    Impulsivity
    apathy
    Compulsive behaviors:hoarding or hypersexuality
    Anger, aggression
    Depression and anxiety
    Sleep issues

Biomarkers

    Alpha-synuclein
    Lysosomal enzymes - Gcase
    Pentraxin 3 (PTX3)
    Orexin
    DJ-1

Pathology

    Loss of dopaminergic neurons
    Lewy bodies
    Oxidative stress
    Muscle stiffness
    Slowness of movement
    Impaired balance and coordination

Frontotemporal Dementia (FTD)

Behaviour

    Impulsivity
    Inappropriate behavior
    Loss of inhibitions
    Lack of empathy
    Loss of interest
    Depression and Anxiety

Biomarkers

    Neurofilament light chain (NfL)
    Progranulin (PGRN)
    Tau
    C9ORF72

Pathology

    TDP-43
    Pick bodies
    FUS

Epilepsy

Behaviour

    Emotional changes: Depression, irritability, anxiety,
    Hyperactivity
    Aggression
    Movement and coordination
    Behavioral epileptic seizures

Biomarkers

    CD40
    Glial fibrillarycidic protein (GFAP)
    MicroRNAs

Pathology

    Neuron loss
    Astrocyte changes
    Axonal sprouting
    Focal cortical dysplasia
    Neoplasms

Amyloid Polyneuropathy

Behaviour

    Balance difficulties
    Sexual dysfunction
    Autonomic dysfunction
    Sweating abnormalities
    Painful neuropathy

Biomarkers

    Skin biopsy
    Cerebrospinal fluid (CSF) protein
    Neurofilament light chain (NfL)
    Cytokines

Pathology

    Axonal degeneration
    Blood vessel damage
    Schwann cell damage
    Toxic effects
    Axonal sprouting

Friedreich Ataxia (FA)

Behaviour

    Frustration and anxiety
    Depression
    Social withdrawal
    Cognitive changes
    Fatigue

Biomarkers

    Mitochondrial complex I (MC1)
    GPX1
    Troponin T

Pathology

    Nerve fibers
    Dorsal root ganglia
    Cerebellum
    Dentate nuclei
    Myelinated fibers

Krabbe Disease

Behaviour

    Muscle weakness
    Feeding difficulties
    Seizures
    Unexplained fevers
    Holding hands in fists

Biomarkers

    Psychosine
    Galactosylceramide
    Glucosylceramide
    Lyso-Gb1
    Lactosylceramide

Pathology

    Demyelination
    Globoid cells
    Reactive astrocytic gliosis
    Accumulation of psychosine

Cerebral Palsy

Behaviour

    Anxiety & Depression
    Antisocial behaviors
    Hyperactivity
    Frustration and anger
    Dependency

Biomarkers

    Prenatal biomarkers: (PAPP-A)nd (beta-hCG)
    Genetic factors
    Epigenetic markers

Pathology

    Perinatal asphyxia
    Muscle contractures
    Spastic, dyskinetic, ataxic - CP
    Premature birth
    Intracranial hemorrhage

Corticobasal Degeneration (CBD)

Behaviour

    Apathy
    Irritability
    Disinhibition
    Obsessive or impulsive thoughts
    Muscle stiffness

Biomarkers

    Total tau (t-tau)
    Phosphorylated tau (p-tau)
    Amyloid beta (Aβ42)

Pathology

    Astrocytic plaques
    Spongiosis and ballooned neurons
    Tau-positive inclusions

Focal Dystonia

Behaviour

    Repetitive movements, twisting motions, and tremors
    Muscle spasms
    Difficulty with dexterity
    Avoidance behavior
    Anxiety and frustration

Biomarkers

    White matterbnormalities
    Cortical silent period (CSP)
    Motor evoked potential (MEP)
    Machine learning

Pathology

    Network disorder model
    Cerebellar involvement
    Abnormal inhibition
    Dysfunctional inhibitory interneurons that use GABA

Hereditary Neuropathy with Liability to Pressure Palsies (HNPP)

Behaviour

    Episodic nature
    Focal weakness
    Sensory disturbances
    Transient symptoms
    Variable severity

Biomarkers

    Genetic testing: PMP22 gene
    Nerve conduction studies (NCS)
    Electrophysiological findings

Pathology

    Myelin abnormalities
    Tomaculae
    Schwann cell dysfunction

Lambert-Eaton Myasthenic Syndrome (LEMS)

Behaviour

    Proximal muscle weakness
    Exercise facilitation
    Reduced reflexes
    Autonomic symptoms
    Gradual onset
    Fatigue

Biomarkers

    Targetntigen: VGCCs
    Diagnostic test
    Clinical correlation

Pathology

    Autoimmune attack
    Reduced acetylcholine release
    Muscle weakness
    Paraneoplastic association

Meningitis

Behaviour

    Anxiety
    Depression
    Lack of self-esteem and confidence
    Aggression
    Hearing loss

Biomarkers

    White cell count (pleocytosis)
    Glucose
    Protein
    IL-6
    Procalcitonin

Pathology

    Bacterial invasion
    Brain parenchyma damage
    Subarachnoid space inflammation
    Arteritis and phlebitis
    Obstructive hydrocephalus

Moyamoya Disease

Behaviour

    Hyperactivity
    Mood lability
    Poor concentration
    Depression and anxiety
    Seizures

Biomarkers

    Matrix metalloproteinase-9 (MMP-9)
    Vascular endothelial growth factor (VEGF)
    MMP-2
    ACTA2
    RNF213

Pathology

    Intimal thickening
    Media attenuation
    Aberrant distal vascular network
    Smooth muscle cell hyperplasia
    Abnormal angiogenesis

Postpartum Depression

Behaviour

    Social withdrawal
    Fear
    Mood swings: Feeling sad, hopeless, or overwhelmed
    Sleeping problems

Biomarkers

    DNA methylation: HP1BP3nd TTC9B genes
    TNF-α
    Interleukin (IL-6)nd IL-10
    Thyroid hormones

Pathology

    Neurotransmitter changes
    Sleep changes
    Severe anxiety and panic attacks

Progressive Supranuclear Palsy (PSP)

Behaviour

    Apathy
    Impulsivity
    Irritability
    Depression
    Emotional dysregulation

Biomarkers

    Neurofilament light chain
    Tau protein
    Glial fibrillarycidic protein (GFAP)
    Amyloid beta-peptides (Aβ)

Pathology

    Neurofibrillary tangles
    Neuronal loss
    Gliosis
    Eye movement abnormalities

Spinocerebellar Ataxia (SCA)

Behaviour

    Motor impairments: ataxia
    Speech difficulties
    Abnormal eye movements like nystagmus
    Speech difficulties
    Depression and anxiety
    Social withdrawal

Biomarkers

    Neurofilament light chain (NfL)
    α-synuclein
    GFAP
    MutantTXN3

Pathology

    Protein aggregation
    Mitochondrial dysfunction
    Calcium homeostasis
    Affected Brain Regions
    Neurodegeneration Cascade

Syringomyelia

Behaviour

    Loss of bladder and bowel control
    Excessive sweating
    Fluctuating blood pressure
    Uncoordinated movements
    Muscle contractions

Biomarkers

    CSF flow dynamics
    Inflammatory markers: S-100β, neuron-specific enolase
    Primary diagnostic marker

Pathology

    Fluid-filled cyst
    syrinx

Trigeminal Neuralgia

Behaviour

    Social isolation
    Depression
    Suicidal thoughts
    Avoidance
    Safety behaviors

Biomarkers

    C-reactive protein (CRP)
    Procalcitonin (PCT)
    Neuron-specific enolase (NSE)
    Clec11a
    LGMN

Pathology

    Demyelination
    Vascular compression
    Lesions

Alzheimer’s Disease (AD)

Behaviour

    Memory Loss
    Depression
    Aggression
    Weight loos
    Social Isolation
    Lack of Sleep

Biomarkers

    Amyloid-beta
    Tau
    Flotillin
    Insulin pathway proteins

Pathology

    Stroke
    Brain volume decreases
    Neurofibrillary Tangles
    Brian Atrophy
    Plaques

Lewy Body Dementia (LBD)

Behaviour

    Hallucinations
    Delusions
    Depression, anxiety, lack of interest
    Lack of Sleep
    Managing behavioral changes

Biomarkers

    Phospho-tau proteinnd Tau-protein
    Neurofilaments (NFs)
    Alpha-synuclein
    YKL-40 protein
    Contactin-1

Pathology

    Lewy bodies
    Lewy neurites
    Amyloid-β plaques
    Mitochondrial dysfunction
    Protein degradation pathway impairment

Rett Syndrome

Behaviour

    Hand stereotypies
    Anxiety
    Social withdrawal
    Self-injurious behavior
    Sleep disturbances

Biomarkers

    Geneticnalysis of MECP2 gene
    Brainctivity through EEG
    Cerebrospinal fluid (CSF) proteinnalysis
    Auditory evoked potentials (AEP)

Pathology

    Neuronal dysfunction
    Oxidative stress
    Brain size
    Peripheral pathologies

Congenital Myopathies

Behaviour

    Floppiness
    Falling or stumbling
    Difficulty breathing
    Difficulty feeding
    Craniofacial dysmorphism

Biomarkers

    Muscle biopsy
    Creatine kinase (CK)
    Genetic testing: RYR1 gene

Pathology

    Heterogeneity
    Muscle fiber abnormalities
    Actin aggregates
    Cylindrical spirals

Batten Disease

Behaviour

    Personality changes
    Slow learning
    Clumsiness or stumbling
    Difficulty concentrating
    Lack of sleep

Biomarkers

    Genetic testing
    Brain volumetry
    Gait impairment

Pathology

    Lysosomal dysfunction
    Glial reactivity
    Neuronal loss
    Peripheral nerve involvement
    Skeletal muscle involvement

Ataxia-Telangiectasia

Behaviour

    Jerky or involuntary movements
    Unsteady gait, difficulty walking
    Speech difficulties
    Progression
    Social and emotional impacts: Anxiety

Biomarkers

    Alpha-fetoprotein (AFP)
    Neurofilament light chain (NfL)
    Oxidative stress markers
    Genetic testing
    Immunoglobulin levels

Pathology

    DNA repair defect
    Cellular consequences
    Neurological manifestations
    Telangiectasia
    Immunodeficiency

Charcot-Marie-Tooth Disease (CMT)

Behaviour

    Depression
    Sleep impairment
    Muscle weakness
    neuropathic pain
    Walking pattern (gait).

Biomarkers

    Neurofilament light (NfL)
    Neural celldhesion molecule 1 (NCAM1)
    Growth differentiation factor 15 (GDF-15)
    Glial fibrillarycid protein (GFAP)
    Fibroblast growth factor 21 (FGF-21)

Pathology

    Genetic defects
    Demyelination
    Axonal degeneration
    Schwann cell dysfunction

Dystonia

Behaviour

    Anxiety
    Prosocial difficulties
    Functional impact
    Sensory tricks
    Dystonia

Biomarkers

    DNA methylation
    Microstructural neural networks
    Neurophysiological signals

Pathology

    Sensorimotor circuitry
    Central nervous system
    Genetic mutations: TOR1A gene
    Blepharospasm

Guillain-Barré Syndrome (GBS)

Behaviour

    Progressive weakness
    Sensory abnormalities
    Loss of reflexes
    Muscle pain
    Autonomic dysfunction
    Respiratory complications

Biomarkers

    Neurofilaments
    Tau proteins
    14-3-3 proteins
    Neuron-specific enolase

Pathology

    Inflammatory lesions
    Myelin damage
    Lymphocytes
    Axonal degeneration
    Wallerian degeneration

Hyperekplexia

Behaviour

    Muscle stiffness (hypertonia)
    Exaggerated startle reflex
    Falling episodes
    Delayed motor development
    Anxiety and fear

Biomarkers

    Genetic sequencing: GLRA1, SLC6A5, GLRB, GPHN,ndRHGEF9
    Linkagenalysis
    Haplotypenalysis

Pathology

    Startle response
    Hip dislocation
    Myoclonus
    Apnea
    Muscle rigidity

Leigh Syndrome

Behaviour

    Vomiting
    Irritability or continuous crying
    Poor feeding or sucking
    Diarrhea
    Lethargy and drowsiness

Biomarkers

    Lacticcid levels
    Plasmaminocids
    Urinary organiccids
    Carnitine panel

Pathology

    Lesions
    Hyperlacticacidemia
    Gliosis
    Vessel hypertrophy

Migraine

Behaviour

    Fatigue
    Irritability
    Digestive issues
    Migraine triggers
    Psychological stressors

Biomarkers

    Calcitonin gene-related peptide (CGRP)
    Inflammatory markers: Suchs CRP, TNF-α, interleukins
    Endothelial progenitor cells (EPCs)
    Oxidative stress markers

Pathology

    Neuropeptides
    Trigeminovascular system
    Sub-cortical aminergic sensory modulatory systems
    Cortical spreading depression (CSD)

Pelizaeus-Merzbacher Disease

Behaviour

    Motor skill delays
    Speech difficulties
    Ataxia
    Chorea: Jerking movements
    Developmental regression

Biomarkers

    Chromosomal microarray testing
    Fluorescence in-situ hybridization (FISH)
    Genetic testing for PLP1 gene mutations
    Droplet-digital polymerase chain reaction (dd-PCR)

Pathology

    Myelin loss
    Oligodendrocyte loss
    Misfolded PLP
    Endoplasmic reticulum (ER) stress
    Ataxia
    Motor ability loss

Primary Lateral Sclerosis (PLS)

Behaviour

    Emotional lability
    Social cognition deficits
    Muscle weakness
    Fatigue
    Spasms

Biomarkers

    Neurofilament light chain (NfL)
    Chitinase
    Phosphorylated neurofilament heavy chain (pNFH)
    Genetic testing: SOD1 or C9orf72 genes

Pathology

    Brain atrophy
    Loss of pyramidal neurons
    White matter degeneration
    Upper motor neuron dysfunction

Restless Leg Syndrome (RLS)

Behaviour

    Irresistible urge to move legs
    Pacing
    Restlessness
    Sleep disruption
    Nighttime aggravation

Biomarkers

    Iron deficiency
    Hypoxia-related proteins
    Epigenetic markers
    C-reactive protein (CRP)nd interleukin-6 (IL-6)

Pathology

    Dopamine dysfunction
    Central nervous system (CNS) iron depletion
    Genetic factors

Stiff-Person Syndrome

Behaviour

    Fear of leaving the house
    Anxiety and depression
    Hunched posture
    Difficulty walking
    Falls

Biomarkers

    Anti-GAD65ntibody
    Anti-amphiphysinntibody
    Anti-GABARAPntibody

Pathology

    GABA pathway disruption
    Paraneoplastic
    Impaired synaptic inhibition
    Muscle hyperactivity

Tardive Dyskinesia

Behaviour

    Facial movements: Lip smacking
    Body movements: Arm twitching
    Involuntary
    Stereotyped
    Social impact

Biomarkers

    GPX1, MDA1, CAT1,nd TNF-α
    Malondialdehyde
    Superoxide dismutase
    Lipid hydroperoxide

Pathology

    Dopamine
    GABA
    Oxidative stress

Tetanus

Behaviour

    Irritability
    Delirium
    Seizures
    Muscle stiffness
    Fever and sweating

Biomarkers

    Anti-tetanus toxinntibodies
    H3F3A K28M

Pathology

    Entry into the body
    Production of toxin
    Spread of toxin
    Autonomic dysfunction
    Effect on the nervous system
bottom of page